All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

What to know before investing in life sciences

Managing IP Correspondent
May 31, 2005
Share
mip-dna-jun05.gif

By their nature, life science companies are among the more IP-dependent businesses in the corporate world. Any transactions, therefore, will require a more thorough due diligence than is the norm. Paul M Booth and Leslie Mooi outline 10 things you should know about such a company before deciding to invest in, or acquire, it

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

FeaturesUnited StatesNorth AmericaNorth AmericaJurisdictions
managing-ip.png
Managing IP Correspondent
Contact

More from across our site

António Campinos wins new EPO term
António Campinos wins new EPO term (but tensions remain)
António Campinos will serve another five-years as EPO president – perhaps he’ll calm unrest at the office in that time
Max Walters, June 29, 2022
AdobeStock_277739388.jpg
Firms must go beyond ‘empty’ LGBTQ gestures after pride month
LGBTQ IP lawyers say using rainbow colours and posting solidarity messages on social media must be followed by concrete action
Max Walters, June 29, 2022
Hidden links-comp.jpg
Why brand owners struggle with hidden links
Brand owners bemoan counterfeiters’ latest wheeze and say enforcement authorities should get more involved
Max Walters, June 29, 2022
Covid 19 vaccine
WTO waiver spurs in-house fears of broader deals
Counsel at Bayer, Novartis, a generics company and other firms debate what the WTO’s patent waiver will mean in the short and long term
Rani Mehta, June 29, 2022
Kathi Vidal
Breaking: USPTO releases Section 101 report
The patent office report found that stakeholders were still divided over subject matter eligibility but broadly wanted clarity
Rani Mehta, June 28, 2022
Datamining
UK to expand data mining freedoms for AI
The UKIPO published the results of its consultation on AI and IP today, June 28, and plans to shake up the rules on copyright and data
Rory O’Neill, June 28, 2022
metaverse-comp.jpg
Exclusive: European IP firm to set up metaverse office
IP consultancy Brandit is the first European intellectual property firm to announce plans for an augmented-reality presence
Max Walters, June 28, 2022
Patrick Leahy, one of the sponsors of the PTAB Reform Act
Leahy-Tillis ‘Fintiv killer’ bill met with patent owner disdain
Patent owners and implementers weigh in on the PTAB Reform Act – its provisions, what it missed and its likelihood of success
Patrick Wingrove, June 27, 2022
FintivGuidenceJune24COVER.jpg
Fintiv guidance vexes doctrine’s in-house backers and critics
Counsel from Blackbird, Unified Patents, two other companies and a law firm debate what new ways to avoid Fintiv mean for petitioners and patent owners
Rani Mehta, June 24, 2022
PTABinhouseweantCOVER.jpg
What in-house want from PTAB lawyers
Counsel at six companies say experience, technical expertise and persuasion are some of the most important skills at the board
Rani Mehta, June 24, 2022
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree